We are live on ! Find out more
ACH

Accendra Health
ACH

229 hedge funds and large institutions have $944M invested in Accendra Health in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 95 increasing their positions, 73 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 73

6% more capital invested

Capital invested by funds: $892M → $944M (+$52.1M)

1.29% less ownership

Funds ownership: 92.74% → 91.45% (-1.3%)

5% less funds holding

Funds holding: 242 → 229 (-13)

31% less call options, than puts

Call options by funds: $4.94M | Put options by funds: $7.2M

34% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 35

Holders
229
Holders Change
-13
Holders Change %
-5.37%
% of All Funds
5.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
95
Reduced
73
Closed
35
Calls
$4.94M
Puts
$7.2M
Net Calls
-$2.27M
Net Calls Change
+$4.02M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.1M
2
JP Morgan Chase
JP Morgan Chase
New York
+$8.63M
3
BlackRock
BlackRock
New York
+$6.58M
4
Invesco
Invesco
Georgia
+$5.64M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.69M

Top Sellers

Rank Fund Capital Flow
1
Pzena Investment Management
Pzena Investment Management
New York
-$22.9M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$3.86M
3
Prudential Financial
Prudential Financial
New Jersey
-$3.73M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.65M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.55M

ACH Hedge Fund Activity: Q2 2018 in Review

229 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q2 2018, worth a combined $944M — up 5.8% from $892M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of ACH and 23 opened new positions — a net loss of 12 holders — while 73 trimmed existing stakes and 95 added.

The largest buyer was Morgan Stanley, adding an estimated $10.1M. The largest seller was Pzena Investment Management, exiting entirely with an estimated $22.9M sold.

  • 229 institutional investors held Accendra Health (ACH) as of Q2 2018, down from 242 in Q1 2018.
  • Funds reported $944M of Accendra Health stock for Q2 2018, up 5.8% quarter-over-quarter.
  • 23 funds opened new Accendra Health positions in Q2 2018 and 35 closed out, a net change of -12 holders.
  • The largest Accendra Health buyer in Q2 2018 was Morgan Stanley, an estimated $10.1M added.
  • The largest Accendra Health seller in Q2 2018 was Pzena Investment Management, an estimated $22.9M sold.

Based on aggregated 13F filings for Q2 2018.